跳至主要内容
临床试验/NCT04513795
NCT04513795Unknown不适用

EARLY-MYO-SEPSIS (EARLY Assessment of MYOcardial Injury in Sepsis Patient) Registry

RenJi Hospital0 个研究点目标入组 300 人开始时间: 2020年9月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
300
主要终点
composite of death, stroke, heart failure

研究概览

简要总结

The diagnosis and pathophysiology of sepsis-induced cardiac dysfunction remain unknown. This registry is to evaluate characteristics of sepsis patients by multi-modalities imaging, including echocardiography, cardiovascular magnetic resonance imaging in 300 patients in 5 sites. Subjects will be followed up to 2 years.

详细描述

Approximately 20-30 million patients worldwide suffer from sepsis every year, which is increasing at the rate of 8% to 13% per year. It is possible that sepsis progress to multiple organ dysfunction in the early stage, with a fatality of 30% to 60%. Myocardium is one of the most vulnerable tissue under the abnormal 'inflammation storm'.Cardiac dysfunction is one of the important predictors for mortality of sepsis.Patients with myocardial depression have an apparently higher mortality rate (70%) as compared with septic patients without cardiac impairment (20%).

Although several trials had explored the diagnosis and treatment of sepsis-induced cardiac dysfunction, the effective characteristic depict and effective therapy remain incompletely understand.

This is a prospective, multi-center, non-randomized, observational registry study of sepsis patients that undergo multi-modality imaging.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 85 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patiants meets the criteria of Sepsis 3.0 as below:
  • Sepsis is a lifethreatening organ dysfunction caused by a dysregulated host response to infection
  • 1 patients in ICU:
  • 1.1 have at least one organ dysfunction
  • 1.2 SOFA score ≥2
  • 2 patients not in ICU
  • 2.1 have at least one organ dysfunction
  • 2.2 SOFA score or qSOFA score ≥2

排除标准

  • Patient who is unable to comply with the follow-up schedule.
  • Patient who has any medical conditions that in the opinion of the investigators will not be appropriate to participate in the study.
  • Patient has a life expectancy of less than 6 months due to any condition

结局指标

主要结局

composite of death, stroke, heart failure

时间窗: 2 years

composite of death, stroke, heart failure

次要结局

  • day of hospitalization(through study completion, 2 months)

研究者

申办方类型
Other
责任方
Sponsor

相似试验

EARLY-MYO-SEPSIS Registry | 临床试验